Veterinary Medicines

Selevitan vet. 50 mg/ml+0,6 mg/ml Injektionsvätska, lösning

Authorised
  • DL-ALPHA TOCOPHEROL ACETATE
  • SODIUM SELENITE ANHYDROUS
Download as PDF

Product identification

Medicine name:
Selevitan vet. 50 mg/ml+0,6 mg/ml Injektionsvätska, lösning
Active substance:
  • DL-ALPHA TOCOPHEROL ACETATE
  • SODIUM SELENITE ANHYDROUS
Target species:
  • Sheep
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • DL-ALPHA TOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • SODIUM SELENITE ANHYDROUS
    1.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        2
        day
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        2
        day
    • Pig
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CE99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Pharmaxim AB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 9498
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 10/08/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 10/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."